BioDelivery Sciences International, Inc. NASDAQ:BDSI

BioDelivery Sciences International stock price today

$5.59
Financial Health
0
1
2
3
4
5
6
7
8
9

BioDelivery Sciences International stock price monthly change

+0.36%
month

BioDelivery Sciences International stock price quarterly change

+82.68%
quarter

BioDelivery Sciences International stock price yearly change

+61.09%
year

BioDelivery Sciences International key metrics

Market Cap
577.05M
Enterprise value
442.03M
P/E
6.81
EV/Sales
5.25
EV/EBITDA
16.08
Price/Sales
6.55
Price/Book
2.93
PEG ratio
0.03
EPS
0.85
Revenue
166.70M
EBITDA
44.54M
Income
84.86M
Revenue Q/Q
2.34%
Revenue Y/Y
6.54%
Profit margin
100.82%
Oper. margin
44.11%
Gross margin
72.23%
EBIT margin
44.11%
EBITDA margin
26.72%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

BioDelivery Sciences International stock price history

BioDelivery Sciences International stock forecast

BioDelivery Sciences International financial statements

BioDelivery Sciences International, Inc. (NASDAQ:BDSI): Profit margin
Mar 2021 41.02M 5.23M 12.77%
Jun 2021 41.43M 9.06M 21.87%
Sep 2021 41.09M 6.66M 16.23%
Dec 2021 43.15M 63.89M 148.05%
BioDelivery Sciences International, Inc. (NASDAQ:BDSI): Earnings per share (EPS)
2021-08-04 0.05 0.09
2021-11-03 0.06 0.07
2022-03-09 0.02 0.62
BioDelivery Sciences International, Inc. (NASDAQ:BDSI): Debt to assets
Mar 2021 242130000 133.27M 55.04%
Jun 2021 250327000 136.40M 54.49%
Sep 2021 256070000 133.29M 52.05%
Dec 2021 324596000 136.77M 42.14%
BioDelivery Sciences International, Inc. (NASDAQ:BDSI): Cash Flow
Mar 2021 11.09M -296K -5.94M
Jun 2021 9.23M -119K -5.69M
Sep 2021 6.96M -6.45M -19.64M
Dec 2021 13.74M -1K -148K

BioDelivery Sciences International alternative data

BioDelivery Sciences International, Inc. (NASDAQ:BDSI): Employee count
Aug 2023 200
Sep 2023 200
Oct 2023 200
Nov 2023 200
Dec 2023 200
Jan 2024 200
Feb 2024 200
Mar 2024 200
Apr 2024 200
May 2024 200
Jun 2024 200
Jul 2024 200

BioDelivery Sciences International other data

BioDelivery Sciences International, Inc. (NASDAQ:BDSI): Insider trades (number of shares)
Period Buy Sel
May 2021 315500 0
Nov 2021 483800 10000
Dec 2021 18587 0
Feb 2022 0 18541
Transaction Date Insider Security Shares Price per share Total value Source
Option
BAILEY JEFFREY ALLEN director, officer.. Restricted Stock Units 5,333 N/A N/A
Option
BAILEY JEFFREY ALLEN director, officer.. Common Stock 5,333 N/A N/A
Sale
VOLLINS JAMES officer: General .. Common Stock 18,541 $3.6 $66,748
Option
PLESHA SCOTT M. officer: Presiden.. Restricted Stock Units 45,253 N/A N/A
Option
PLESHA SCOTT M. officer: Presiden.. Common Stock 24,203 N/A N/A
Option
VOLLINS JAMES officer: General .. Restricted Stock Units 28,413 N/A N/A
Option
VOLLINS JAMES officer: General .. Common Stock 12,137 N/A N/A
Option
SMITH THOMAS B officer: Chief Medical Officer
Restricted Stock Units 32,576 N/A N/A
Option
SMITH THOMAS B officer: Chief Medical Officer
Common Stock 15,215 N/A N/A
Option
PLESHA SCOTT M. officer: Presiden.. Common Stock 21,050 N/A N/A
Patent
Application
Filling date: 7 Feb 2022 Issue date: 21 Jul 2022
Application
Filling date: 27 Dec 2021 Issue date: 30 Jun 2022
Application
Filling date: 25 Dec 2021 Issue date: 16 Jun 2022
Application
Filling date: 15 Sep 2021 Issue date: 10 Mar 2022
Application
Filling date: 10 Oct 2020 Issue date: 20 Jan 2022
Application
Filling date: 22 Mar 2021 Issue date: 9 Sep 2021
Application
Filling date: 12 Feb 2021 Issue date: 19 Aug 2021
Application
Filling date: 30 Jan 2021 Issue date: 22 Jul 2021
Application
Filling date: 16 Jul 2020 Issue date: 7 Jan 2021
Application
Filling date: 30 Apr 2020 Issue date: 19 Nov 2020
Friday, 18 March 2022
Zacks Investment Research
Wednesday, 2 March 2022
Zacks Investment Research
Thursday, 24 February 2022
Zacks Investment Research
Tuesday, 15 February 2022
Zacks Investment Research
Monday, 14 February 2022
InvestorPlace
GuruFocus
PennyStocks
Market Watch
Monday, 7 February 2022
Zacks Investment Research
Monday, 24 January 2022
The Motley Fool
PennyStocks
Friday, 21 January 2022
PennyStocks
Zacks Investment Research
Monday, 20 December 2021
Pulse2
The Motley Fool
PennyStocks
PennyStocks
Friday, 3 December 2021
Zacks Investment Research
Wednesday, 10 November 2021
PennyStocks
Wednesday, 3 November 2021
Seeking Alpha
Zacks Investment Research
Tuesday, 21 September 2021
Zacks Investment Research
Tuesday, 14 September 2021
PennyStocks
Sunday, 12 September 2021
PennyStocks
Thursday, 9 September 2021
Seeking Alpha
Tuesday, 7 September 2021
GlobeNewsWire
Friday, 3 September 2021
GlobeNewsWire
Friday, 27 August 2021
Seeking Alpha
Friday, 20 August 2021
PennyStocks
  • What's the price of BioDelivery Sciences International stock today?

    One share of BioDelivery Sciences International stock can currently be purchased for approximately $5.59.

  • When is BioDelivery Sciences International's next earnings date?

    Unfortunately, BioDelivery Sciences International's (BDSI) next earnings date is currently unknown.

  • Does BioDelivery Sciences International pay dividends?

    No, BioDelivery Sciences International does not pay dividends.

  • How much money does BioDelivery Sciences International make?

    BioDelivery Sciences International has a market capitalization of 577.05M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 6.54% to 166.7M US dollars. BioDelivery Sciences International earned 84.86M US dollars in net income (profit) last year or $0.62 on an earnings per share basis.

  • What is BioDelivery Sciences International's stock symbol?

    BioDelivery Sciences International, Inc. is traded on the NASDAQ under the ticker symbol "BDSI".

  • What is BioDelivery Sciences International's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of BioDelivery Sciences International?

    Shares of BioDelivery Sciences International can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are BioDelivery Sciences International's key executives?

    BioDelivery Sciences International's management team includes the following people:

    • Mr. Scott M. Plesha Pres & Chief Commercial Officer(age: 60, pay: $629,460)
    • Mr. Jeffrey Allen Bailey Chief Executive Officer & Director(age: 62, pay: $599,960)
    • Mr. James Vollins J.D. Gen. Counsel, Chief Compliance Officer & Corporation Sec.(age: 56, pay: $586,680)
    • Dr. Thomas B. Smith FAAFP, M.D. Chief Medical Officer(age: 64, pay: $570,060)
  • How many employees does BioDelivery Sciences International have?

    As Jul 2024, BioDelivery Sciences International employs 200 workers.

  • When BioDelivery Sciences International went public?

    BioDelivery Sciences International, Inc. is publicly traded company for more then 23 years since IPO on 25 Jul 2002.

  • What is BioDelivery Sciences International's official website?

    The official website for BioDelivery Sciences International is bdsi.com.

  • Where are BioDelivery Sciences International's headquarters?

    BioDelivery Sciences International is headquartered at 4131 Parklake Ave Ste 225, Raleigh, NORTH CAROLINA.

  • How can i contact BioDelivery Sciences International?

    BioDelivery Sciences International's mailing address is 4131 Parklake Ave Ste 225, Raleigh, NORTH CAROLINA and company can be reached via phone at +1 919 582 9050.

BioDelivery Sciences International company profile:

BioDelivery Sciences International, Inc.

bdsi.com
Exchange:

NASDAQ

Full time employees:

200

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; and Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. The company also provides ELYXYB, a celecoxib oral solution for the treatment of migraine with or without aura in adults; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina. As of March 18, 2022, BioDelivery Sciences International, Inc. operates as a subsidiary of Collegium Pharmaceutical, Inc.

4131 Parklake Ave Ste 225
Raleigh, NORTH CAROLINA 27612

CIK: 0001103021
ISIN: US09060J1060
CUSIP: 09060J106